Volume 25, Number 1—January 2019
Synopsis
Clinical and Radiologic Characteristics of Human Metapneumovirus Infections in Adults, South Korea
Hyun Jung Koo, Han Na Lee, Sang-Ho Choi, Heungsup Sung, Hwa Jung Kim, and Kyung-Hyun Do
Table 5
CT findings for 251 patients with HMPV pneumonia without another pathogen, South Korea*
| Characteristic | Immunocompetent | Solid tumors | SOT | HCT | HM | Steroid use | Total |
|---|---|---|---|---|---|---|---|
| Patients with HMPV pneumonia without another pathogen | 259 | 81 | 36 | 7 | 29 | 41 | 453 |
| Patients who underwent CT scans | 138 | 43 | 26 | 3 | 23 | 18 | 251 |
| Bilateral | 100 (72.5) | 34 (79.1) | 21 (80.8) | 3 (100) | 20 (87.0) | 14 (77.8) | 192 (76) |
| No. involved lobes | 3 (2–6) | 5 (3–6) | 4 (2–5) | 6 (6–6) | 5 (3–6) | 4 (3–5) | 4 (2–6) |
| Macronodule | 67 (49) | 19 (44) | 11 (31) | 1 (33) | 12 (52) | 4 (22) | 114 (45) |
| Patients with centrilobular nodules | 101 (73) | 28 (65) | 17 (47) | 2 (67) | 13 (57) | 13 (72) | 174 (69) |
| Extent of centrilobular nodules | 10 (5–30) | 10 (0–20) | 10 (0–20) | 20 (10–20) | 10 (0–20) | 10 (0–23) | 10 (5–20) |
| Patients with consolidation | 57 (41) | 20 (47) | 13 (50) | 0 | 8 (35) | 9 (50) | 107 (43) |
| Extent of consolidation | 0 (0–10) | 0 (0–15) | 3 (0–10) | 0 (0–0) | 0 (0–10) | 8 (0–20) | 0 (0–10) |
| Patients with ground-glass opacity | 109 (79) | 38 (88) | 21 (81) | 2 (67) | 15 (65) | 14 (78) | 199 (79) |
| Extent of ground-glass opacity | 10 (10–20) | 10 (10–30) | 10 (10–23) | 10 (10–10) | 10 (5–20) | 18 (9–33) | 10 (10–20) |
| Bronchial wall thickening | 121 (88) | 35 (81) | 25 (96) | 3 (100) | 1 (4) | 17 (94) | 222 (88) |
| Bronchiectasis | 17 (12) | 4 (9) | 4 (15) | 1 (33) | 3 (13) | 5 (28) | 34 (14) |
| Cavitation | 1 (0.7) | 0 | 0 | 0 | 0 | 1 (6) | 2 (1) |
| Lymphadenopathy | 40 (29) | 14 (33) | 6 (23) | 0 (0) | 2 (9) | 6 (33) | 68 (27) |
| Pleural effusion | 24 (17) | 15 (35) | 7 (27) | 1 (33) | 5 (22) | 4 (22) | 56 (22) |
*Values are no. (%) or median (interquartile range) unless otherwise indicated. CT, computed tomography; HCT, hematologic stem cell transplantation; HM, hematologic malignancy; LRD, lower respiratory tract disease; SOT, solid organ transplants; URI, upper respiratory tract infection.
Page created: December 18, 2018
Page updated: December 18, 2018
Page reviewed: December 18, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.